We are live on
!
Find out more
JHP
James Hambro & Partners Portfolio holdings
AUM
$2.76B
1-Year Est. Return
19.67%
This Fund
S&P 500
This Quarter
Est. Return
-2.37%
1 Year Est. Return
+19.67%
3 Year Est. Return
+79.16%
5 Year Est. Return
+89.36%
10 Year Est. Return
–
AUM
$1.54B
AUM Growth
+$27.7M
(+1.8%)
Cap. Flow
+$66.5M
Cap. Flow
% of AUM
4.31%
Top 10 Holdings %
Top 10 Hldgs %
59.28%
Holding
63
New
3
Increased
19
Reduced
19
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$97.9M |
| 2 |
Aon
AON
|
+$67.4M |
| 3 |
Danaher
DHR
|
+$40M |
| 4 |
Intuitive Surgical
ISRG
|
+$14.6M |
| 5 |
UnitedHealth
UNH
|
+$9.63M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$12M |
| 2 |
IBM
IBM
|
+$11.5M |
| 3 |
JPMorgan Chase
JPM
|
+$1.93M |
| 4 |
TJX Companies
TJX
|
+$1.16M |
| 5 |
Pfizer
PFE
|
+$1.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.45% |
| 2 | Technology | 20.84% |
| 3 | Healthcare | 18.37% |
| 4 | Industrials | 8.54% |
| 5 | Communication Services | 7.38% |
Similar funds
NSLI
JFGIW
LGP
SAM
HRCM
SFFS
CC
MC
James Hambro & Partners's Q3 2023 Portfolio in Review
As of Q3 2023, James Hambro & Partners held 63 positions worth $1.54B, up 1.8% from $1.52B the previous quarter. Its ten largest holdings account for 59% of the portfolio.
James Hambro & Partners deployed $66.5M of net new capital in Q3 2023, opening 3 new positions and adding to 19 existing holdings. Its largest new stake was Linde: 257,126 shares worth $95.8M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 22% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Union Pacific, an estimated $12M trimmed.
- James Hambro & Partners's largest Q3 2023 buy was Linde: 257,126 shares worth $95.8M.
- James Hambro & Partners added most to Danaher in Q3 2023, an estimated $40M increase.
- James Hambro & Partners's biggest Q3 2023 reduction was Union Pacific, cutting an estimated $12M.
- James Hambro & Partners fully exited Pfizer in Q3 2023, selling an estimated $1.05M.
- James Hambro & Partners's ten largest holdings make up 59% of its $1.54B portfolio in Q3 2023.
- James Hambro & Partners opened 3 new positions and closed 9 in Q3 2023.
- James Hambro & Partners's portfolio value rose 1.8% quarter-over-quarter to $1.54B.
Based on James Hambro & Partners's 13F filing for Q3 2023, filed 24 Oct 2023.